Psoriasis: all 1,928 studies

Page 13 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.

• A Pilot Study to Explore the Role of Gut Flora in PsoriasisWithdrawnNCT04099979
• Tissue Sodium in Patients With PsoriasisCompletedNCT04095130
• Therapeutic Drug Monitoring of Ixekizumab in Psoriasis PatientsCompletedNCT04083612Phase 4
• Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients.CompletedNCT04080661Phase 4
• Therapeutic Drug Monitoring of Guselkumab in Psoriasis PatientsCompletedNCT04080648Phase 4
• A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque PsoriasisCompletedNCT04080206Phase 2
• Prevalence of Sonographic Abnormalities of Joints and Entheses in Psoriasis Patients With or Without Musculoskeletal ComplainsCompletedNCT04074070
• Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical TrialStatus unknownNCT04071106Phase 2/3
• A Study of KHK4827 in Subjects With Palmoplantar PustulosisCompletedNCT04061252Phase 3
• Use of Transcutaneous Electrical Nerve Stimulation for Reducing Biologic Injection Site Pain(TENS Study)Active, not recruitingNCT04058652Not applicable
• A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical PracticeCompletedNCT04053881
• Prevalence of Psoriasis and Vitiligo in Assiut Governorate, EgyptStatus unknownNCT04039451
• Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With PsoriasisCompletedNCT04036435Phase 3
• A Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseSuspendedNCT04031469
• A Study to Describe the Characteristics of Patients Treated With Apremilast for Plaque Psoriasis in Italian Routine Clinical PracticeCompletedNCT04031027
• Dose Tapering Study of Adalimumab in PsoriasisTerminatedNCT04028713Phase 4
• Comparison of PK and Tolerability of MSB11022 Administered by AI or PFSCompletedNCT04018599Phase 1
• Identification of the Best Self-questionnaire to Diagnose Depression in Patients With Psoriasis (DePsoVal)CompletedNCT04013867
• A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular PsoriasisCompletedNCT03998683Phase 3
• A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque PsoriasisCompletedNCT03988439Phase 4
• A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque PsoriasisActive, not recruitingNCT03987763Phase 4
• Iontophoresis in PsoriasisWithdrawnNCT03979664Early Phase 1
• Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar PustulosisCompletedNCT03972280Phase 1
• A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With PsoriasisTerminatedNCT03971825Phase 1
• An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their ProvidersCompletedNCT03964168
• Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Heat SyndromeStatus unknownNCT03961230Phase 2
• Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With PsoriasisCompletedNCT03960450Phase 1
• Ultrasound Enthesitis Response in Psoriatic ArthritisCompletedNCT03955861
• Fire Needle Therapy on Plaque Psoriasis With Blood Stasis SyndromeStatus unknownNCT03953885Not applicable
• Moving Cupping for Plaque Psoriasis: a Randomized Controlled TrialStatus unknownNCT03952676Not applicable
• A Clinical Observation on the Efficacy and Safety of Pulsed Dye Laser (PDL) in the Treatment of Nail PsoriasisCompletedNCT03946826Not applicable
• Chinese Herbal Medicine for Psoriasis Vulgaris: a Real World StudyStatus unknownNCT03942185Phase 2
• Sequential Treatment of Psoriasis With Integrated Traditional Chinese and Western MedicineStatus unknownNCT03941431Phase 2
• The Effect of Periodontal Treatment on PsoriasisCompletedNCT03939936Not applicable
• Metabolic Syndrome in Psoriasis and Psoriatic Arthritis and Correlation With Serum Omentin and Visfatin LevelsCompletedNCT03932110Not applicable
• The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque PsoriasisStatus unknownNCT03927352Phase 3
• Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in KoreaCompletedNCT03925441
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque PsoriasisCompletedNCT03922607Phase 1
• Studying the Effect of Methotrexate Alone Versus Methotrexate and Vitamin D on the Cardiovascular Risk of Psoriatic PatientsStatus unknownNCT03904680Phase 4
• Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.CompletedNCT03898583Phase 1
• Autologous Natural Killer Cells in Subjects With Plaque PsoriasisCompletedNCT03894579Phase 1
• Serum Level of Bioactive Mediators and Urinary Biopyrins in PsoriasisStatus unknownNCT03889938
• Mind-Body Approaches for Medical ConditionsStatus unknownNCT03888261Not applicable
• Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous StudyActive, not recruitingNCT03886246Phase 2
• To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp PsoriasisCompletedNCT03880357Phase 1
• Combined Oral Vitamin D and UVB Versus UVB Alone in Treatment of Psoriasis VulgarisStatus unknownNCT03874975Early Phase 1
• Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy MalesCompletedNCT03873415Phase 1
• The Effectiveness of a Mindful Parenting Intervention for Parents of Children With Psoriasis and Parents of Children With EczemaCompletedNCT03873142Not applicable
• The Inner Ear Function in Psoriatic PatientsCompletedNCT03865030Not applicable
• • Sleep Disturbance Among Patients With Psoriasis and Atopy and Comparison Between ThemStatus unknownNCT03864809
• Efficacy, Safety, and Immunogenicity of AVT02 With Moderate-to-Severe Chronic Plaque PsoriasisCompletedNCT03849404Phase 3
• Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque PsoriasisCompletedNCT03848806Phase 2
• PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
• Clinical, Psychological and Genetic Characteristics in Dermatological PatientsCompletedNCT03831646
• Secukinumab Efficacy Without the Initial Loading Dose in Patients With PsoriasisCompletedNCT03828643
• FibroScan ® Study: Assessing Liver Fibrosis in Patients Using Methotrexate for PsoriasisWithdrawnNCT03820934Not applicable
• Efficacy and Safety Study of Autonomic Nerve Modulation (ANM) in Subjects With Moderate Plaque PsoriasisStatus unknownNCT03817164Not applicable
• Discovery of Arthritis in Psoriasis Patients for Early Rheumatological ReferralCompletedNCT03816917
• Comparison of Scalp Microbiota of the Psoriasis and Seborrheic Dermatitis PatientsCompletedNCT03807453
• Study to Assess the Safety and Tolerability of PBF-1650 in Healthy Volunteers.CompletedNCT03798236Phase 1
• Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcriptomics ProfilingCompletedNCT03795402
• Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After TreatmentCompletedNCT03791216
• Genetic Analysis of Pediatric PsoriasisCompletedNCT03768284
• Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative ColitisTerminatedNCT03768219Phase 1
• Estimation of Level of ERAP1 Expression in Lesional and Non Lesional Skin of Psoraitic Patients and Healthy Controls.CompletedNCT03767114Not applicable
• Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem CellsStatus unknownNCT03765957Early Phase 1
• Janus Kinase 1 in Vitiligo & PsoriasisCompletedNCT03762551Not applicable
• A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque PsoriasisCompletedNCT03759197Phase 3
• Methotrexate in the Treatment of Distal Interphalangeal Joint Extensor Tendon Enthesopathy in Nail PsoriasisCompletedNCT03757364
• A Study to Assess Benefits of Apremilast in Patients With Moderate to Severe Chronic Plaque Psoriasis Followed by Dermatologists Under Real Life Settings in FranceCompletedNCT03757013
• Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe PsoriasisStatus unknownNCT03745417Phase 1/2
• Psoriatic Arthritis and Psoriasis Treatment Decision AidCompletedNCT03737045Not applicable
• A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic DermatitisCompletedNCT03733353Phase 1
• To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).CompletedNCT03731091Phase 3
• Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)CompletedNCT03731052Phase 3
• An Ascending Multiple Dose Study With VTP-43742 in Healthy VolunteersCompletedNCT03724292Phase 1
• A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque PsoriasisStatus unknownNCT03710681Phase 1
• The Safety and Efficacy of a Novel HSP90 Inhibitor (CUDC-305) in the Treatment of Moderate to Severe Psoriasis.Status unknownNCT03675542Phase 1
• Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque PsoriasisCompletedNCT03669757Phase 1
• Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis VulgarisTerminatedNCT03662685Phase 1
• A Longitudinal Observational Study of Patients Undergoing Therapy for IMISCActive, not recruitingNCT03661866
• Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune DiseaseTerminatedNCT03656627Phase 1
• An Open-Label Study to Assess SafetyCompletedNCT03645499Phase 1
• A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque PsoriasisCompletedNCT03630939Phase 1/2
• Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid MetabolismStatus unknownNCT03629639Phase 4
• Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin LesionsCompletedNCT03629379Phase 4
• A Study of AK111 in Healthy SubjectsCompletedNCT03622021Phase 1
• Quality of Life and Ultrasonographic Assessment of Nail Psoriasis After Treatment With Apremilast (JUST Study)CompletedNCT03616561
• Effect of Sublimated Mare Milk Supplement on Gut Microbiome in Psoriasis PatientsCompletedNCT03594877Not applicable
• A Study to Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque PsoriasisCompletedNCT03591887Phase 2
• Role of Topical Treatments in the Modulation of Skin Microbiome in Psoriatic SkinCompletedNCT03584360Phase 2
• A Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2CompletedNCT03580278Phase 1
• A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy VolunteersStatus unknownNCT03577626Phase 1
• Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy SubjectsStatus unknownNCT03570346Phase 1
• Apremilast Treatment for Pruritus and Quality of Life in Scalp PsoriasisStatus unknownNCT03553433Phase 4
• A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic DermatitisCompletedNCT03542994Phase 1
• Study to Evaluate the Benefits for the Patient Associated With the Treatment of Plaque Psoriasis With Apremilast After Other Systemic Treatment in Conditions of Clinical Practice in SpainCompletedNCT03539419
• Aggressive Weight Loss Program in Chronic Plaque PsoriasisCompletedNCT03531528Not applicable
• The Effect of NB-UVB on Interleukin-36 Levels in PsoriasisStatus unknownNCT03526705Not applicable
• Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian FederationCompletedNCT03518047Phase 3

← Psoriasis overview